Analisa Biaya Pengobatan Demam Tifoid Berdasarkan Clinical Pathway Di Rumah Sakit Harapan Bunda

Authors

  • Pieter Hazmen Fakultas Farmasi Universitas Pancasila
  • Shirly Kumala Fakultas Farmasi Universitas Pancasila
  • Prih Sarnianto Fakultas Farmasi Universitas Pancasila

DOI:

https://doi.org/10.33533/jpm.v13i2.1314

Keywords:

Branded, Ceftriaxone, Clinical pathway, Typhoid fever, Generic

Abstract

Clinical pathways are used in quality and cost control with indicators of length of stay. Cases of typhoid fever at Harapan Bunda Hospital include the criteria for the first rank of High Volume in 2018 and Problem Prone in the cost of treatment. The purpose of the study is to analyze the cost of treatment based on the implementation of clinical pathways in antibiotic therapy. Observational research with comparative studies of the use of injection antibiotics based on clinical pathway implementation. Retrospective data collection with dependent outcome therapy variables (cost and length of stay) while the independent variable regimen of antibiotic use. The population of typhoid fever patients according to the criteria for the implementation of clinical pathway ICD code (A0.10) 571 patients. Samples using total sampling that fulfills the criteria of direct inclusion are made into samples divided by the antibiotic regimen of the payment system, the group with the least amount excluded. There were 4 observation groups: generic ceftriaxone (n = 52) branded ceftriaxone (n = 51), generic cefotaxime (n = 53) and branded cefotaxime (n = 57) totaling 213 patients. Satatistic test results of length of stay (p> 0.05) explained that they did not have a significant difference, the average value (5.1596). Medical expenses for generic cefotaxime (Rp 4,072,002,6792), generic cherryax (Rp 4,479,480,4808), branded cefotaxime (Rp 6,945,258,3333) and branded ceftriaxone (Rp 7,296,933,5686). Conclusions based on JKN (AMiB) antibiotic payment systems are cheaper than general and the cheapest cefotaxime cheapest generic antibiotics.

References

Faradina N, Fadilah N, Budi SC, Iii D, Medis R, Vokasi S. Efektifitas Implementasi Clinical Pathway Terhadap Average Length Of Stay dan Outcomes Pasien DF-DHF Anak di RSUD Kota Yogyakarta. Jkesvo (Jurnal Kesehat Vokasional). 2017;2(2):175–81.

Sutoto, DR. Dr. M. Kes, Sudigdo Sastroasmoro. Prof, DR, Dr SpA (K), Wasista Budiwaluyo DM. Panduan Praktik Klinis Dan Clinical Pathway Dalam Asuhan Terintegrasi Sesuai Standar Akreditasi Rumah Sakit 2012. 2015th ed. Jakarta; 2015. 1-216 p.

Nimah K, Nurwahyuni A. Evaluasi Implementasi Clinical Pathway Apendisitis Akut Terhadap Tagihan Pasien Di Rumah Sakit X . University of Indonesia. 2017;1–20.

Rahmasari V, Lestari K. Manajemen Terapi Demam Tifoid: Kajian Terapi Farmakologis Dan Non Farmakologis. J Farmaka. 2018;16(1):184–95.

Kemetrian Kesehatan Republik Indonesia. Keputusan Mentri Kesehatan Republik Indonesia Nomor 363/Menkes/SK/V/2006. Jakarta, Indonesia: Menteri Kesehatan Republik Indonesia; 2006 p. 1–41.

Raflizar, Holly M. Association of Determinant Factors with Prevalence of Typhoid in Java Ocean. J Ekol Kesehat Vol 9 No 4. 2010;1(1):1357–65.

Haluang O, Tjitrosantoso H, Kojong NS. Demam Tifoid Anak Di Instalasi Rawat Inap Rsup Prof . Dr . R . D . Kandou Manado. J Ilm Farm. 2015;4(3):117–25.

Kemetrian Kesehatan Republik Indonesia. Pedoman Penerapan Kajian Farmakoekonomi. Drs. Prih Sarnianto, M.Sc A, dr. Zorni Fadia, Erie Gusnellyanti, S.Si, Apt M, editors. Kementrian Kesehatan Republik Indonesia. Jakarta: Kementrian Kesehatan Republik Indonesia; 2013. 31-37 p.

Dwi TCA, Musthofa SB. Faktor – Faktor Yang Berhubungan Dengan Praktik Hidup Bersih Dan Sehat Sebagai Upaya Pencegahan Demam Tifoid Pada Siswa Di Sdn Genuksari 02 Semarang. J Kesehat Masy. 2018;6(1):826–34.

Rosyid A, Santoso A, Andriani IT. Analisis Efektivitas Biaya Pengobatan Penggunaan Sefotaxim Dan Seftriaxon Pada Pasien Demam Tifoid Anak Rawat Inap Di Rumah Sakit Islam Sultan Agung Semarang. ISSN- Online 2548 – 3897. 2018;1(1):31–9.

Virdania KV, Laksemi DAAS, Damayanti PAA. Hubungan Umur Dengan Jenis Rawat Dan Lama Hari Rawat Inap Pasien Demam Tifoid Di Rsup Sanglah Denpasar Tahun 2014. E-Jurnal Med VOL 7 NO7. 2018;7(7):1–7.

Jannah N, Ihwan, Tandah MR. Efektifitas Biaya Penggunaan Seftriakson Dan Sefiksim Pada Pasien Demam Tifoid Rawat Inap Di Rsu Anutapura Palu Periode 2015-2017. J Ilm Medicam. 2019;5(1):45–50.

Hanifah HZ, Sari IP, Nuryastuti T. Evaluasi Penggunaan Antibiotik Empiris dan Analisis Biaya Demam Tifoid di Sebuah RS Swasta Kota Semarang. J Sains Farm Dan Klin. 2018;5(1):1–6.

Downloads

Additional Files

Published

2019-12-23

How to Cite

Hazmen, P., Kumala, S., & Sarnianto, P. (2019). Analisa Biaya Pengobatan Demam Tifoid Berdasarkan Clinical Pathway Di Rumah Sakit Harapan Bunda. Jurnal Profesi Medika : Jurnal Kedokteran Dan Kesehatan, 13(2). https://doi.org/10.33533/jpm.v13i2.1314

Issue

Vol. 13 No. 2 (2019): Jurnal Profesi Medika : Jurnal Kedokteran dan Kesehatan

Section

Article

License

Copyright Notice

All articles submitted by the author and published in the Jurnal Profesi Medika : Jurnal Kedokteran dan Kesehatan, are fully copyrighted by the publication of Jurnal Profesi Medika : Jurnal Kedokteran dan Kesehatan under the Creative Commons Attribution-NonCommercial 4.0 International License by technically filling out the copyright transfer agreement and sending it to the publisher

Note :

The author can include in separate contractual arrangements for the non-exclusive distribution of rich versions of journal publications (for example: posting them to an institutional repository or publishing them in a book), with the acknowledgment of their initial publication in this journal.

Authors are permitted and encouraged to post their work online (for example: in an institutional repository or on their website) before and during the submission process because it can lead to productive exchanges, as well as earlier and more powerful citations of published works. (See Open Access Effects).